Herboxidiene
(Synonyms: GEX1A) 目录号 : GC40103Herboxidiene 作为一种有效的抗肿瘤剂,可以靶向剪接体的 SF3B 亚基。
Cas No.:142861-00-5
Sample solution is provided at 25 µL, 10mM.
Herboxidiene, as a potent antitumor agent, can target the SF3B subunit of the spliceosome. Herboxidiene also induces both G1 and G2/M cell cycle arrest in a human normal fibroblast cell line WI-38.[1].
In vitro, herboxidiene showed cytotoxicity with IC50 of 0.0037 to approximately 0.99 μM against human tumor cell lines, while herboxidiene were not active against both gram-positive and -negative bacteria.[3] in addition, Herboxidiene has cytotoxicity against A431, A549, and DLD-1 cells with IC50s of 3.7, 21, 51 nM, respectively.[6] In vitro efficacy test it shown that in a dose-response assay, 0.5 μM Herboxidiene had substantial inhibitory effects on the plant growth and development comparable to those of 1 μM pladienolide B.[2] In vitro, treatment with herboxidiene at 5 μM had an effect on cell and nuclei shape, suggesting there is a cellular toxicity at high concentrations.[4] In addition, herboxidiene (a less potent, structurally different splicing modulator) at 20?nM (~3 × GI50) in HCT116 cells has the possibility of resistant clone generation.[5] Herboxidiene has a cytostaticity against human umbilical vein endothelial cells with IC50 of 26 nM and has inhibition with VEGF-induced invasion and tube formation of serum-starved HUVECs in a concentration-dependent manner[7].
In vivo experiment it exhibited that treatment with 1 mg/kg herboxidiene intraperitoneally once shown obvious antitumor activity[6].
References:
[1]Ghosh AK, et al. Design and synthesis of herboxidiene derivatives that potently inhibit in vitro splicing. Org Biomol Chem. 2021 Feb 18;19(6):1365-1377.
[2]AlShareef S, et al. Herboxidiene triggers splicing repression and abiotic stress responses in plants. BMC Genomics. 2017 Mar 27;18(1):260.
[3]Sakai Y, et al. GEX1 compounds, novel antitumor antibiotics related to herboxidiene, produced by Streptomyces sp. I. Taxonomy, production, isolation, physicochemical properties and biological activities. J Antibiot (Tokyo). 2002 Oct;55(10):855-62.
[4]Granatosky EA, et al. GEX1A, a Polyketide from Streptomyces chromofuscus, Corrects the Cellular Defects Associated with Niemann-Pick Type C1 in Human Fibroblasts. J Nat Prod. 2018 Sep 28;81(9):2018-2025.
[5]Teng T, et al. Splicing modulators act at the branch point adenosine binding pocket defined by the PHF5A-SF3b complex. Nat Commun. 2017 May 25;8:15522.
[6]Miller-Wideman M, et al. Herboxidiene, a new herbicidal substance from Streptomyces chromofuscus A7847. Taxonomy, fermentation, isolation, physico-chemical and biological properties. J Antibiot (Tokyo). 1992 Jun;45(6):914-21.
[7]Jung HJ, et al. Antiangiogenic activity of herboxidiene via downregulation of vascular endothelial growth factor receptor-2 and hypoxia-inducible factor-1α. Arch Pharm Res. 2015 Sep;38(9):1728-35.
Herboxidiene 作为一种有效的抗肿瘤剂,可以靶向剪接体的 SF3B 亚基。在人正常成纤维细胞系 WI-38 中,Herboxidiene 还诱导 G1 和 G2/M 细胞周期停滞。[1]。
在体外,herboxidiene 对人类肿瘤细胞系表现出细胞毒性,IC50 为 0.0037 至约 0.99 μM,而 herboxidiene 对革兰氏阳性和阴性细菌均无活性。[ 3] 此外,Herboxidiene 对 A431、A549 和 DLD-1 细胞具有细胞毒性,IC50 分别为 3.7、21、51 nM。[6]< /sup> 体外药效试验表明,在剂量反应试验中,0.5 μM Herboxidiene 对植物生长发育的抑制作用与 1 μM pladienolide B 相当。[2] 在在体外,用 5 μM herboxoxidene 处理对细胞和细胞核形状有影响,表明在高浓度下存在细胞毒性。[4] 此外,herboxidiene(一种效力较低、结构不同的剪接调节剂) 20 nM (~3 × GI50) 在HCT116细胞中有产生抗性克隆的可能性。[5] Herboxidiene对人脐带有细胞生长抑制作用l 静脉内皮细胞,IC50 为 26 nM,以浓度依赖性方式抑制 VEGF 诱导的血清饥饿 HUVEC 的侵袭和管腔形成[7]。
体内实验表明,1 mg/kg herboxoxidiene腹腔注射一次显示出明显的抗肿瘤活性[6]。
Cell experiment [1]: | |
Hela cells |
RAW 264.7 cells |
Preparation Method |
Hela cells were cultured with 0.4 μM Herboxidiene for 4 h. The spliced and unspliced RNAs for the transcripts of DNAJB1, BRD2 and RIOK3 were detected by RT-PCR. |
Reaction Conditions |
0.4 μM; 4h |
Applications |
Herboxidiene inhibited the splicing of other pre-mRNAs. |
References: [1]. Hasegawa M, et al. Identification of SAP155 as the target of GEX1A (Herboxidiene), an antitumor natural product. ACS Chem Biol. 2011 Mar 18;6(3):229-33. |
Cas No. | 142861-00-5 | SDF | |
别名 | GEX1A | ||
化学名 | 5,6-anhydro-6-C-[(2S,3E,5E)-6-[(2S,3S,6R)-6-(carboxymethyl)tetrahydro-3-methyl-2H-pyran-2-yl]-2-methyl-3,5-heptadien-1-yl]-1,4,7-trideoxy-4-methyl-3-O-methyl-L-glycero-L-gluco-heptitol | ||
Canonical SMILES | O=C(O)C[C@@H]1O[C@H](/C(C)=C/C=C/[C@@H](C)C[C@@]2(C)O[C@]2([H])[C@H](C)[C@@H](OC)[C@H](O)C)[C@@H](C)CC1 | ||
分子式 | C5H42O6 | 分子量 | 438.6 |
溶解度 | Soluble in ethanol or methanol or DMSO or dichloromethane | 储存条件 | Store at -20°C,protect from light |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
![]() |
1 mg | 5 mg | 10 mg |
1 mM | 2.28 mL | 11.3999 mL | 22.7998 mL |
5 mM | 0.456 mL | 2.28 mL | 4.56 mL |
10 mM | 0.228 mL | 1.14 mL | 2.28 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >70.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet